Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program
Go back to Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program| Omeros Corporation (NASDAQ: OMER) | Delayed: 17.36 +0.17 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.19 | 52 Week High | $16.80 | |||
| Open | $17.17 | 52 Week Low | $7.20 | |||
| Day High | $17.52 | P/E | N/A | |||
| Day Low | $16.90 | EPS | $-1.64 | |||
| Volume | 2,466,520 | |||||
